Back

Plasma level of extracellular matrix biomarkers is associated with the recurrence of atrial fibrillation

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation recurrence: clinical, genetic, and biomarker predictors Defining Types of Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Simon Andrup

Oslo University Hospital Ulleval, Oslo (Norway)

5 More presentations in this session

Presentation thumbnail
Peak atrial longitudinal strain in predicting recurrence of atrial fibrillation after cardioversion
Doctor A. Garner (Slagelse, DK)
Abstract
Presentation thumbnail
Predictors of long-term atrial fibrillation recurrence following catheter ablation: a UK multicenter study
Doctor N. Chandan (Coventry, GB)
Abstract
Presentation thumbnail
Baseline multidomain atrial vulnerability stratifies recurrence after AF ablation in elderly patients
Professor D. Malidze (Tbilisi, GE)
Abstract
Presentation thumbnail
SCN5A H558R polymorphism reduces the risk of flecainide-related toxicity and inefficacy
Mr M. Trincado Ave (Santiago de Compostela, ES)
Abstract
Presentation thumbnail
REVERSE-AF Score: development of a clinical tool to predict atrial fibrillation recurrence after electrical cardioversion
Doctor M. Santos Silva (Aveiro, PT)
Abstract

Access the full session

Session thumbnail
Atrial fibrillation recurrence: clinical, genetic, and biomarker predictors

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Predictive value of biomarker dynamics for atrial fibrillation recurrence after pulmonary vein isolation: a prospective cohort study
30 March 2025
thumbnail
Congress Presentation
A biomarker of collagen type I is associated with risk of mortality after ST-elevated myocardial infarction
21 May 2023
thumbnail
Congress Presentation
Angiopoietin-like protein (Angptl) 2 secreted from epicardial adipose tissue induces atrial myocardial fibrosis
1 September 2019
thumbnail
Congress Presentation
Regional levels of tenascin- C in patients with heart failure and atrial fibrillation
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources